Selective JAK1 Inhibition Using Upadacitinib for the Management of Inflammatory Bowel Diseases: The Powerful Pill. Can IBD Today [Internet]. 23 nov. 2023 [cité 31 mars 2026];1(S11):2–11. Disponible à: https://canadianibdtoday.com/article/view/1-s11-narula_hamam